We found 51 snoRNAs/scaRNAs associated with the clinicopathological characteristics of BC including tumor grade, the hormone receptor status of the tumors, molecular subtype, and tumor histology offering further candidates for prognostic and therapeutic markers for ilBC. Here, NR4A1 is linked to breast cancer.